Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle - Wikidata - awgldk - TriplyDB

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

http://www.wikidata.org/entity/Q28266084

about

Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.Microarray-based analysis of fish egg quality after natural or controlled ovulation Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.Myofibrillogenesis regulator 1 induces hypertrophy by promoting sarcomere organization in neonatal rat cardiomyocytes.High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.Tissue-specific temporal exome capture revealed muscle-specific genes and SNPs in Indian buffalo (Bubalus bubalis).The sarcomeric M-region: a molecular command center for diverse cellular processes.Kidney protection against ischemia/reperfusion injury by myofibrillogenesis regulator-1.MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway.Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence.Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.Myofibrillogenesis regulator-1 attenuated hypoxia/reoxygenation-induced apoptosis by inhibiting the PERK/Nrf2 pathway in neonatal rat cardiomyocytes.Silencing MR-1 attenuates atherosclerosis in ApoE-/- mice induced by angiotensin II through FAK-Akt-mTOR-NF-kappaB signaling pathway.

P2860

Q24301472-E5C4D09D-EB81-431F-8B94-C335EC647DB6 Q26775167-A3825DD0-31A4-4194-87BF-95660351580A Q28277525-D9ABE569-8307-42BF-B4EA-29235F7DB5B7 Q28291175-C65653BF-85D2-456F-9413-A2CEEA420747 Q33221703-517B1697-B0F1-4071-BDAA-92922A95C36D Q33274898-628F807A-8588-47F3-A2F3-524ECD35D18B Q33942459-7247726C-D61F-49D1-A081-A1D00EC5B9D3 Q34458551-01644B77-4EB2-4865-B864-5F0C7DE5C3C0 Q36011135-C7D2DA8C-0C06-43A4-BA5B-2605FDE332A6 Q36464650-5DDFD701-5EEA-466E-BC70-36EF26B4AD48 Q36736547-BEBDD56C-0343-4AAC-AD9A-DE5F3EDB373F Q37318570-42513546-CBE3-4629-B9E4-903D46776350 Q38471353-F4E7B541-CC0F-4DFC-9284-FFFCA5375F91 Q39006233-C64DC0C2-444F-44FB-8CF2-62E0CE2CAD08 Q39925975-63DBD933-262E-432D-BC26-06550C87D263 Q43859646-A8CB2F8A-EBBD-41CB-BCEE-4A3406986A15 Q47441027-2C3C419E-1853-44C0-A798-14B66BCDF686 Q50132710-6AAF542C-4BA8-4237-958A-641793132085 Q51672326-8ED9EB4F-554B-416F-8FA1-969D84EC5EB2 Q52665659-C14F4914-B1F9-4465-BB70-2FD3FD1F4062

P2860

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

http://www.wikidata.org/entity/Q28266084

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@ast

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@en

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@nl

type

label

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@ast

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@en

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@nl

prefLabel

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@ast

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@en

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@nl

P1433

Q28266084-B8461EE2-9C1E-49D6-AE43-18AF0428784A

P1476

Q28266084-1DEABC1E-5F89-4DB3-A984-1DE30AD8A6B2

P2093

Q28266084-153E10EB-A8DA-484A-AE8F-A00EADAD75FA

Q28266084-7360EB11-F4A2-4C51-90C9-84A5BFC77977

Q28266084-7C8DFE0A-01C7-4571-9380-53A3051A0CD7

Q28266084-ABA32DBC-812F-4C3C-BC9E-ACEC605A2E7A

Q28266084-C3266AE2-EC1F-4916-80BC-14BF4E7A1B79

Q28266084-D1BB84DB-26D3-4296-8461-28B149BB69D3

Q28266084-D5D57D23-21ED-46B6-B5C3-22EC3E78E569

Q28266084-F9DD8BA5-03B3-454A-B6AB-97588B13F977

P304

Q28266084-89654B63-2EFC-4B2D-9253-8A4FCCE49587

P31

Q28266084-BCC176A5-D6D9-4379-8BD2-4AB934A4256C

P356

Q28266084-96B5AC52-8CCE-4947-A11B-EE68E8BD8165

P407

Q28266084-22E609F0-E8A5-449E-B9C8-35FD8E7B1AFB

P433

Q28266084-83CA4C8F-8DE8-4D3C-95FE-211954F018E8

P478

Q28266084-E10BF881-EB4E-491D-B301-C7029AB774DA

P577

Q28266084-9D2F68BB-DD70-41F0-B2DF-9FA8A20068D9

P5875

Q28266084-A575255B-EBF2-40D2-A281-DAFBAC481625

P698

Q28266084-504D6D50-6CAF-4DDE-8637-D8280DFA2606

P356

P1433

Acta Biochimica et Biophysica Sinica

P1476

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

@en

P2093

Li-Min Gong

http://www.w3.org/2001/XMLSchema#string

Shuang Feng

http://www.w3.org/2001/XMLSchema#string

Tian-Bo Li

http://www.w3.org/2001/XMLSchema#string

Wei-Xi Yang

http://www.w3.org/2001/XMLSchema#string

Xiu-Hua Liu

http://www.w3.org/2001/XMLSchema#string

Yang Hu

http://www.w3.org/2001/XMLSchema#string

Yi-Guang Wang

http://www.w3.org/2001/XMLSchema#string

Yue Han

http://www.w3.org/2001/XMLSchema#string

P304

412-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ABBS/36.6.412

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8519218

http://www.w3.org/2001/XMLSchema#string

P698

15188056

http://www.w3.org/2001/XMLSchema#string